Literature DB >> 33599108

Synthesis and Assessment of Fused β-Carboline Derivatives as Kappa Opioid Receptor Agonists.

Veena D Yadav1, Lalan Kumar1, Poonam Kumari2, Sakesh Kumar2,3, Maninder Singh4, Mohammad I Siddiqi4,3, Prem N Yadav2,3, Sanjay Batra1,3.   

Abstract

The synthesis of 5-formyl-6-aryl-6H-indolo[3,2,1-de][1,5] naphthyridine-2-carboxylates by reaction between 1-formyl-9H-β-carbolines and cinnamaldehydes in the presence of pyrrolidine in water with microwave irradiation is described. Pharmacophoric modification of the formyl group offered several new fused β-carboline derivatives, which were investigated for their κ-opioid receptor (KOR) agonistic activity. Two compounds 4 a and 4 c produced appreciable agonist activity on KOR with EC50 values of 46±19 and 134±9 nM, respectively. Moreover, compound-induced KOR signaling studies suggested both compounds to be extremely G-protein-biased agonists. The analgesic effect of 4 a was validated by the increase in tail flick latency in mice in a time-dependent manner, which was completely blocked by the KOR-selective antagonist norBNI. Moreover, unlike U50488, an unbiased full KOR agonist, 4 a did not induce sedation. The docking of 4 a with the human KOR was studied to rationalize the result.
© 2021 Wiley-VCH GmbH.

Entities:  

Keywords:  beta-carboline; kappa opioid receptor agonist; molecular modeling; nitrogen heterocycle; pain

Mesh:

Substances:

Year:  2021        PMID: 33599108     DOI: 10.1002/cmdc.202100029

Source DB:  PubMed          Journal:  ChemMedChem        ISSN: 1860-7179            Impact factor:   3.466


  1 in total

Review 1.  An updated assessment of the translational promise of G-protein-biased kappa opioid receptor agonists to treat pain and other indications without debilitating adverse effects.

Authors:  Alexander R French; Richard M van Rijn
Journal:  Pharmacol Res       Date:  2022-01-29       Impact factor: 7.658

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.